“sanofi” Archives

in
Entry Author Date Location
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More 10/08/15 Boston
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round 09/08/15 Boston
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer 09/01/15 Boston
Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+ 09/01/15 Boston
With FDA OK, Amgen’s Heart Drug Faces Rival (And Health Budgets) 08/27/15 National
Ex-Teva CEO’s Brain Disease Startup, Ovid, Bags $75M From Crossovers 08/11/15 New York
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
Beer Out as Struggling Aegerion Shuffles Leadership Ranks 07/27/15 Boston
FDA OKs Cholesterol Fighter Praluent For More Patients Than Expected 07/24/15 New York
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
Scynexis Sells CRO Business to Avista, Turns Focus to Antifungal Drug 07/23/15 Raleigh Durham
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
Texas Roundup: SailPoint, DEC, Neos, Sanofi, NASA & XPrize 07/17/15 Texas
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors 07/07/15 Detroit Ann Arbor
How Pozen’s Tribute Pharma Deal Paves New Path for “Safer Aspirin” 06/16/15 Raleigh Durham
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Rare Heart Disease Advocate: “I’m More Relieved Than I’ve Ever Been” 06/10/15 National
Advisors to FDA: Approve New Cholesterol Drug, But With Caveats 06/10/15 National
Take a Grain of Salt (Or Two) With New Cholesterol Drug Predictions 06/09/15 National
East Coast Biotech Roundup: Seres, Editas, PureTech, Pronutria & More 05/29/15 Boston
Retrophin Turns Asklepion Voucher Into $245M Sanofi Payday 05/27/15 New York
Page 3 of 9 « previous page · next page »